The latest news and updates about NYSCF and our collaborators
The Context: Age-related macular degeneration (AMD) is a disease which affects 8 million Americans and can lead to severe vision loss due to death of retinal...
Perhaps in the past few years, you’ve started to hear more about CRISPR gene editing— the revolutionary technique that allows us to precisely manipulate the DNA...
The Context: It is estimated that 15 million babies are born prematurely each year, and a common premature birth complication is low oxygen levels. We know...
The Context: Patients suffering from stroke, paralysis, ALS, Parkinson’s, and many other conditions are often left with impaired speaking and gesturing abilities, and there are few...
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
Women’s reproductive cancers—such as ovarian cancer, endometrial cancer, uterine cancer, and cervical cancer—are especially difficult to treat. Mortality rates are high (32,000 women die from these...
NYSCF – Robertson Stem Cell Investigator, CRISPR pioneer, and MIT Professor of Brain and Cognitive Sciences and Biological Engineering Dr. Feng Zhang and his collaborators have...
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...
The Context: In multiple sclerosis, the immune system attacks myelin (the fatty substance that surrounds neurons and helps them send signals). Currently, there are no...
44 million people worldwide are affected by Alzheimer’s. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is...
The Context: When a major heart artery is blocked, the oxygen-starved areas of the heart are kept healthy by smaller arteries called collateral arteries. Some people...
What they did: A team of researchers from Stanford University led by NYSCF – Robertson Neuroscience Investigator and Assistant Professor of Anesthesiology, Neurosurgery, and Perioperative and...
Research teams will use stem cell and gene editing technologies to advance cell-based therapies for devastating diseases New York, New York (January 9, 2019) – The...
“It takes 13 years—after you have sunk 4 billion dollars into a drug—to figure out whether or not it will succeed, and your chance of being...
Our skin is made up of three layers. The top layer – the epidermis – contains epithelial cells, which provide a barrier between us and the...
What They Did: A team of researchers from MIT led by NYSCF – Robertson Neuroscience Investigator and Associate Professor in Brain and Cognitive Sciences Kay Tye,...
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
What they did: A team of scientists including NYSCF Scientific Advisor and Harvard University Professor of Stem Cell and Regenerative Biology Dr. Kevin Eggan and NYSCF...
The National Stem Cell Foundation (NSCF), Summit for Stem Cell Foundation, The New York Stem Cell Foundation (NYSCF) Research Institute, and Space Tango today announced a...
NEW YORK, NY (October 23, 2018) – The New York Stem Cell Foundation (NYSCF) announced the 2018 class of NYSCF – Robertson Investigators, welcoming six of...
What they did: NYSCF–Robertson Stem Cell Investigator Dr. Sergiu Pasca of Stanford University has pioneered a new method for generating 3D aggregates of region-specific brain tissue...
Years ago, a physician in her sixties started to develop a tremor. She sought treatment from Dr. Susan Bressman, who diagnosed her with Parkinson’s disease. The...
We are pleased to announce that Gist Croft, PhD, has joined NYSCF as a Senior Principal Investigator in Parkinson’s disease and Neurodegeneration. Dr. Croft— an expert...
In a new article from the patient advocacy and research nonprofit Jordan’s Guardian Angels, NYSCF speaks about its work creating induced pluripotent stem cells from patients with Jordan’s...
New collaboration aims to develop better therapies New York, NY (August 1, 2018) – The New York Stem Cell Foundation (NYSCF) Research Institute today announced a...
